Cargando…
Relationships of Coagulation Factor XIII Activity with Cell-Type and Stage of Non-Small Cell Lung Cancer
PURPOSE: Factor XIII (FXIII), a thrombin-activated plasma transglutaminase zymogen, is involved in cancer development and progression through a triggered coagulation pathway. The aim of this study was to examine whether FXIII activity levels differed in non-small cell lung cancer (NSCLC) patients ac...
Autores principales: | Lee, Seung Heon, Suh, In Bum, Lee, Eun Joo, Hur, Gyu Young, Lee, Sung Yong, Lee, Sang Yeub, Shin, Chol, Shim, Jae Jeong, In, Kwang Ho, Kang, Kyung Ho, Yoo, Se Hwa, Kim, Je Hyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809885/ https://www.ncbi.nlm.nih.gov/pubmed/24142643 http://dx.doi.org/10.3349/ymj.2013.54.6.1394 |
Ejemplares similares
-
The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer
por: Lee, Kyoung Ju, et al.
Publicado: (2013) -
A Case of Paraneoplastic Limbic Encephalitis Associated with Small Cell Lung Cancer
por: Ryu, Ja Young, et al.
Publicado: (2012) -
Effects of Transglutaminase 2 Inhibition on Ventilator-Induced Lung Injury
por: Suh, In Bum, et al.
Publicado: (2014) -
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
por: Lee, Seung Hyeun, et al.
Publicado: (2017) -
A Case of IgG4-Related Disease Presenting as Massive Pleural Effusion and Thrombophlebitis
por: Choi, Jong Hyun, et al.
Publicado: (2014)